These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16759108)

  • 1. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
    Nelson DW; Gregg RJ; Kort ME; Perez-Medrano A; Voight EA; Wang Y; Grayson G; Namovic MT; Donnelly-Roberts DL; Niforatos W; Honore P; Jarvis MF; Faltynek CR; Carroll WA
    J Med Chem; 2006 Jun; 49(12):3659-66. PubMed ID: 16759108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
    Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists.
    Nelson DW; Sarris K; Kalvin DM; Namovic MT; Grayson G; Donnelly-Roberts DL; Harris R; Honore P; Jarvis MF; Faltynek CR; Carroll WA
    J Med Chem; 2008 May; 51(10):3030-4. PubMed ID: 18438986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization and gene expression profiling of an L5/L6 spinal nerve ligation model for neuropathic pain in mice.
    Kiso T; Watabiki T; Tsukamoto M; Okabe M; Kagami M; Nishimura K; Aoki T; Matsuoka N
    Neuroscience; 2008 May; 153(2):492-500. PubMed ID: 18400411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists.
    Carroll WA; Kalvin DM; Perez Medrano A; Florjancic AS; Wang Y; Donnelly-Roberts DL; Namovic MT; Grayson G; Honoré P; Jarvis MF
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4044-8. PubMed ID: 17482819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.
    Perez-Medrano A; Donnelly-Roberts DL; Honore P; Hsieh GC; Namovic MT; Peddi S; Shuai Q; Wang Y; Faltynek CR; Jarvis MF; Carroll WA
    J Med Chem; 2009 May; 52(10):3366-76. PubMed ID: 19397270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists.
    Florjancic AS; Peddi S; Perez-Medrano A; Li B; Namovic MT; Grayson G; Donnelly-Roberts DL; Jarvis MF; Carroll WA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2089-92. PubMed ID: 18272366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
    Bunnelle WH; Daanen JF; Ryther KB; Schrimpf MR; Dart MJ; Gelain A; Meyer MD; Frost JM; Anderson DJ; Buckley M; Curzon P; Cao YJ; Puttfarcken P; Searle X; Ji J; Putman CB; Surowy C; Toma L; Barlocco D
    J Med Chem; 2007 Jul; 50(15):3627-44. PubMed ID: 17585748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.
    Yang J; Gharagozloo P; Yao J; Ilyin VI; Carter RB; Nguyen P; Robledo S; Woodward RM; Hogenkamp DJ
    J Med Chem; 2004 Mar; 47(6):1547-52. PubMed ID: 14998340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 1.
    Matasi JJ; Brumfield S; Tulshian D; Czarnecki M; Greenlee W; Garlisi CG; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3805-8. PubMed ID: 21570840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridazinoquinolinetriones as NMDA glycine-site antagonists with oral antinociceptive activity in a model of neuropathic pain.
    Bare TM; Brown DG; Horchler CL; Murphy M; Urbanek RA; Alford V; Barlaam C; Dyroff MC; Empfield JB; Forst JM; Herzog KJ; Keith RA; Kirschner AS; Lee CM; Lewis J; McLaren FM; Neilson KL; Steelman GB; Trivedi S; Vacek EP; Xiao W
    J Med Chem; 2007 Jun; 50(13):3113-31. PubMed ID: 17542571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice.
    Honore P; Donnelly-Roberts D; Namovic M; Zhong C; Wade C; Chandran P; Zhu C; Carroll W; Perez-Medrano A; Iwakura Y; Jarvis MF
    Behav Brain Res; 2009 Dec; 204(1):77-81. PubMed ID: 19464323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazopyridines: a novel class of hNav1.7 channel blockers.
    London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.
    Morytko MJ; Betschmann P; Woller K; Ericsson A; Chen H; Donnelly-Roberts DL; Namovic MT; Jarvis MF; Carroll WA; Rafferty P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2093-6. PubMed ID: 18272365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonists.
    Perez-Medrano A; Donnelly-Roberts DL; Florjancic AS; Nelson DW; Li T; Namovic MT; Peddi S; Faltynek CR; Jarvis MF; Carroll WA
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3297-300. PubMed ID: 21536435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.
    Lee JY; Yu J; Cho WJ; Ko H; Kim YC
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6053-8. PubMed ID: 19800793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Jahangir A; Alam M; Carter DS; Dillon MP; Bois DJ; Ford AP; Gever JR; Lin C; Wagner PJ; Zhai Y; Zira J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1632-5. PubMed ID: 19231178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.